Molecular diagnostic tests detect specific biologic molecules, or biomarkers, in a patient's tissue and fluid samples. Molecular diagnostic tests can be used to select a cancer therapy and/or to monitor the effects of a treatment based on characteristics of or changes in the biomarker.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Molecular Diagnostics Cancer industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
Market Segment by Product Application
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Roche
Invitae
Abbott Laboratories
Danaher
MDxHealth
Siemens
Thermo Fisher Scientific
AstraZeneca
ICON Plc
PlexBio
Foundation Medicine
CytoTrack
Guardant Health
Luminex
10X Genomics
Merck
Biocartis
GenomOncology
Biodesix
Bio-Techne
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Molecular Diagnostics Cancer consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Molecular Diagnostics Cancer market by identifying its various subsegments.
3.Focuses on the key global Molecular Diagnostics Cancer manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Molecular Diagnostics Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Molecular Diagnostics Cancer submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Molecular Diagnostics Cancer Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Molecular Diagnostics Cancer Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Molecular Diagnostics Cancer Segment by Type
2.1.1 Pharmacogenomic Diagnosis
2.1.2 Liquid Biopsy
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Respiratory Cancer
2.2.2 Cancer of Digestive System
2.2.3 Cancer of Urinary System
2.2.4 Cancer of Circulatory System
2.2.5 Motor System Cancer
2.2.6 Reproductive System Cancer
2.2.7 Other
2.3 Global Molecular Diagnostics Cancer Market Comparison by Regions (2017-2027)
2.3.1 Global Molecular Diagnostics Cancer Market Size (2017-2027)
2.3.2 North America Molecular Diagnostics Cancer Status and Prospect (2017-2027)
2.3.3 Europe Molecular Diagnostics Cancer Status and Prospect (2017-2027)
2.3.4 Asia-pacific Molecular Diagnostics Cancer Status and Prospect (2017-2027)
2.3.5 South America Molecular Diagnostics Cancer Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Molecular Diagnostics Cancer Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostics Cancer Industry Impact
2.5.1 Molecular Diagnostics Cancer Business Impact Assessment - Covid-19
2.5.2 Market Trends and Molecular Diagnostics Cancer Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Molecular Diagnostics Cancer Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Molecular Diagnostics Cancer Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Molecular Diagnostics Cancer Manufacturer Market Share
3.5 Top 10 Molecular Diagnostics Cancer Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Molecular Diagnostics Cancer Market
3.7 Key Manufacturers Molecular Diagnostics Cancer Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Molecular Diagnostics Cancer Industry Key Manufacturers
4.1 Roche
4.1.1 Company Details
4.1.2 Roche Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.1.3 Roche Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Invitae
4.2.1 Company Details
4.2.2 Invitae Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.2.3 Invitae Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Invitae News
4.3 Abbott Laboratories
4.3.1 Company Details
4.3.2 Abbott Laboratories Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.3.3 Abbott Laboratories Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Abbott Laboratories News
4.4 Danaher
4.4.1 Company Details
4.4.2 Danaher Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.4.3 Danaher Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Danaher News
4.5 MDxHealth
4.5.1 Company Details
4.5.2 MDxHealth Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.5.3 MDxHealth Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 MDxHealth News
4.6 Siemens
4.6.1 Company Details
4.6.2 Siemens Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.6.3 Siemens Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Siemens News
4.7 Thermo Fisher Scientific
4.7.1 Company Details
4.7.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Thermo Fisher Scientific News
4.8 AstraZeneca
4.8.1 Company Details
4.8.2 AstraZeneca Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.8.3 AstraZeneca Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 AstraZeneca News
4.9 ICON Plc
4.9.1 Company Details
4.9.2 ICON Plc Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.9.3 ICON Plc Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 ICON Plc News
4.10 PlexBio
4.10.1 Company Details
4.10.2 PlexBio Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.10.3 PlexBio Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 PlexBio News
4.11 Foundation Medicine
4.11.1 Company Details
4.11.2 Foundation Medicine Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.11.3 Foundation Medicine Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Foundation Medicine News
4.12 CytoTrack
4.12.1 Company Details
4.12.2 CytoTrack Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.12.3 CytoTrack Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 CytoTrack News
4.13 Guardant Health
4.13.1 Company Details
4.13.2 Guardant Health Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.13.3 Guardant Health Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Guardant Health News
4.14 Luminex
4.14.1 Company Details
4.14.2 Luminex Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.14.3 Luminex Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Luminex News
4.15 10X Genomics
4.15.1 Company Details
4.15.2 10X Genomics Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.15.3 10X Genomics Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 10X Genomics News
4.16 Merck
4.16.1 Company Details
4.16.2 Merck Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.16.3 Merck Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Merck News
4.17 Biocartis
4.17.1 Company Details
4.17.2 Biocartis Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.17.3 Biocartis Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Biocartis News
4.18 GenomOncology
4.18.1 Company Details
4.18.2 GenomOncology Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.18.3 GenomOncology Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 GenomOncology News
4.19 Biodesix
4.19.1 Company Details
4.19.2 Biodesix Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.19.3 Biodesix Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Biodesix News
4.20 Bio-Techne
4.20.1 Company Details
4.20.2 Bio-Techne Molecular Diagnostics Cancer Product Introduction, Application and Specification
4.20.3 Bio-Techne Molecular Diagnostics Cancer Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Bio-Techne News
5 Global Molecular Diagnostics Cancer Sales Categorized by Regions
5.1 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Regions
5.1.1 Global Molecular Diagnostics Cancer Sales and Market Share by Regions (2017-2022)
5.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Regions (2017-2022)
5.2 North America Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
5.3 Europe Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
5.5 South America Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
6 North America Molecular Diagnostics Cancer Market Size Categorized by Countries
6.1 North America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
6.1.1 North America Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
6.1.2 North America Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
6.1.3 United States Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
6.1.4 Canada Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
6.1.5 Mexico Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
6.2 North America Molecular Diagnostics Cancer Revenue (Value) by Manufacturers
6.3 North America Molecular Diagnostics Cancer Sales and Market Share by Type (2017-2022)
6.4 North America Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
7 Europe Molecular Diagnostics Cancer Market Size Categorized by Countries
7.1 Europe Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
7.1.1 Europe Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
7.1.3 Germany Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.1.4 UK Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.1.5 France Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.1.6 Russia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.1.7 Italy Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.1.8 Spain Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
7.2 Europe Molecular Diagnostics Cancer Revenue (Value) by Manufacturers
7.3 Europe Molecular Diagnostics Cancer Sales and Market Share by Type (2017-2022)
7.4 Europe Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
8 Asia-Pacific Molecular Diagnostics Cancer Market Size Categorized by Countries
8.1 Asia-pacific Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
8.1.3 China Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.1.4 South Korea Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.1.5 Japan Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.1.6 Australia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.1.7 India Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Molecular Diagnostics Cancer Revenue (Value) by Manufacturers
8.3 Asia-pacific Molecular Diagnostics Cancer Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
9 South America Molecular Diagnostics Cancer Market Size Categorized by Countries
9.1 South America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
9.1.1 South America Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
9.1.2 South America Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
9.1.3 Brazil Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
9.2 South America Molecular Diagnostics Cancer Sales and Market Share by Type (2017-2022)
9.3 South America Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
10 Middle East and Africa Molecular Diagnostics Cancer Market Size Categorized by Countries
10.1 Middle East and Africa Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
10.1.3 GCC Countries Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
10.1.4 Turkey Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
10.1.5 Egypt Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
10.1.6 South America Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Molecular Diagnostics Cancer Sales and Market Share by Type
10.3 Middle East and Africa Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
11 Global Molecular Diagnostics Cancer Market Segment by Type
11.1 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Molecular Diagnostics Cancer Sales and Market Share by Type (2017-2022)
11.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2017-2022)
11.2 Pharmacogenomic Diagnosis Sales Growth Rate and Price
11.2.1 Global Pharmacogenomic Diagnosis Sales Growth Rate (2017-2022)
11.2.2 Global Pharmacogenomic Diagnosis Price (2017-2022)
11.3 Liquid Biopsy Sales Growth Rate and Price
11.3.1 Global Liquid Biopsy Sales Growth Rate (2017-2022)
11.3.2 Global Liquid Biopsy Price (2017-2022)
11.4 Other Sales Growth Rate and Price
11.4.1 Global Other Sales Growth Rate (2017-2022)
11.4.2 Global Other Price (2017-2022)
12 Global Molecular Diagnostics Cancer Market Segment by Application
12.1 Global Molecular Diagnostics Cancer Sales Market Share by Application (2017-2022)
12.2 Respiratory Cancer Sales Growth Rate (2017-2022)
12.3 Cancer of Digestive System Sales Growth Rate (2017-2022)
12.4 Cancer of Urinary System Sales Growth Rate (2017-2022)
12.5 Cancer of Circulatory System Sales Growth Rate (2017-2022)
12.7 Reproductive System Cancer Sales Growth Rate (2017-2022)
12.8 Other Sales Growth Rate (2017-2022)
13 Global Molecular Diagnostics Cancer Market Forecast
13.1 Global Molecular Diagnostics Cancer Revenue, Sales and Growth Rate (2022-2027)
13.2 Molecular Diagnostics Cancer Market Forecast by Regions (2022-2027)
13.2.1 North America Molecular Diagnostics Cancer Market Forecast (2022-2027)
13.2.2 Europe Molecular Diagnostics Cancer Market Forecast (2022-2027)
13.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Forecast (2022-2027)
13.2.4 South America Molecular Diagnostics Cancer Market Forecast (2022-2027)
13.2.5 Middle East & Africa Molecular Diagnostics Cancer Market Forecast (2022-2027)
13.3 Molecular Diagnostics Cancer Market Forecast by Type (2022-2027)
13.3.1 Global Molecular Diagnostics Cancer Sales Forecast by Type (2022-2027)
13.3.2 Global Molecular Diagnostics Cancer Market Share Forecast by Type (2022-2027)
13.4 Molecular Diagnostics Cancer Market Forecast by Application (2022-2027)
13.4.1 Global Molecular Diagnostics Cancer Sales Forecast by Application (2022-2027)
13.4.2 Global Molecular Diagnostics Cancer Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Molecular Diagnostics Cancer Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Molecular Diagnostics Cancer Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Molecular Diagnostics Cancer
Figure Market Concentration Ratio and Market Maturity Analysis of Molecular Diagnostics Cancer
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Molecular Diagnostics Cancer Market Size by Type
Figure Global Market Share of Molecular Diagnostics Cancer by Type in 2021
Figure Pharmacogenomic Diagnosis Picture
Figure Liquid Biopsy Picture
Figure Other Picture
Table Global Molecular Diagnostics Cancer Market Size (Volume) by Application
Figure Respiratory Cancer Picture
Figure Cancer of Digestive System Picture
Figure Cancer of Urinary System Picture
Figure Cancer of Circulatory System Picture
Figure Motor System Cancer Picture
Figure Reproductive System Cancer Picture
Figure Other Picture
Table Global Molecular Diagnostics Cancer Comparison by Regions (M USD) 2017-2027
Figure Global Molecular Diagnostics Cancer Market Size (Million US$) (2017-2027)
Figure North America Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Molecular Diagnostics Cancer Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Molecular Diagnostics Cancer Sales by Manufacturer (2017-2022)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Manufacturer in 2021
Table Global Molecular Diagnostics Cancer Revenue by Manufacturer (2017-2022)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Manufacturer in 2021
Table Global Molecular Diagnostics Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Molecular Diagnostics Cancer Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Molecular Diagnostics Cancer Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Molecular Diagnostics Cancer Market
Table Key Manufacturers Molecular Diagnostics Cancer Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Roche
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Invitae Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Invitae
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Invitae 2017-2022
Table Invitae Main Business
Table Invitae Recent Development
Table Abbott Laboratories Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Abbott Laboratories
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2017-2022
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Danaher Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Danaher
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Danaher 2017-2022
Table Danaher Main Business
Table Danaher Recent Development
Table MDxHealth Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of MDxHealth
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of MDxHealth 2017-2022
Table MDxHealth Main Business
Table MDxHealth Recent Development
Table Siemens Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Siemens
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Siemens 2017-2022
Table Siemens Main Business
Table Siemens Recent Development
Table Thermo Fisher Scientific Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Thermo Fisher Scientific
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Thermo Fisher Scientific 2017-2022
Table Thermo Fisher Scientific Main Business
Table Thermo Fisher Scientific Recent Development
Table AstraZeneca Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of AstraZeneca
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table ICON Plc Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of ICON Plc
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ICON Plc 2017-2022
Table ICON Plc Main Business
Table ICON Plc Recent Development
Table PlexBio Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of PlexBio
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of PlexBio 2017-2022
Table PlexBio Main Business
Table PlexBio Recent Development
Table Foundation Medicine Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Foundation Medicine
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Foundation Medicine 2017-2022
Table Foundation Medicine Main Business
Table Foundation Medicine Recent Development
Table CytoTrack Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of CytoTrack
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CytoTrack 2017-2022
Table CytoTrack Main Business
Table CytoTrack Recent Development
Table Guardant Health Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Guardant Health
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Guardant Health 2017-2022
Table Guardant Health Main Business
Table Guardant Health Recent Development
Table Luminex Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Luminex
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Luminex 2017-2022
Table Luminex Main Business
Table Luminex Recent Development
Table 10X Genomics Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of 10X Genomics
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 10X Genomics 2017-2022
Table 10X Genomics Main Business
Table 10X Genomics Recent Development
Table Merck Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Merck
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Biocartis Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Biocartis
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocartis 2017-2022
Table Biocartis Main Business
Table Biocartis Recent Development
Table GenomOncology Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of GenomOncology
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GenomOncology 2017-2022
Table GenomOncology Main Business
Table GenomOncology Recent Development
Table Biodesix Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Biodesix
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biodesix 2017-2022
Table Biodesix Main Business
Table Biodesix Recent Development
Table Bio-Techne Company Profile
Table Molecular Diagnostics Cancer Product Introduction, Application and Specification of Bio-Techne
Table Molecular Diagnostics Cancer Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bio-Techne 2017-2022
Table Bio-Techne Main Business
Table Bio-Techne Recent Development
Figure Global Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Global Molecular Diagnostics Cancer Revenue and Growth Rate (2017-2022)
Table Global Molecular Diagnostics Cancer Sales by Regions (2017-2022)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Regions in 2021
Table Global Molecular Diagnostics Cancer Revenue by Regions (2017-2022)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Regions in 2021
Figure North America Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Europe Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Asia-pacific Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure South America Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure North America Molecular Diagnostics Cancer Revenue and Growth Rate (2017-2022)
Table North America Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
Table North America Molecular Diagnostics Cancer Sales Market Share by Countries (2017-2022)
Figure North America Molecular Diagnostics Cancer Sales Market Share by Countries in 2021
Table North America Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
Table North America Molecular Diagnostics Cancer Revenue Market Share by Countries (2017-2022)
Figure North America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2021
Figure United States Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Canada Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Mexico Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Table North America Molecular Diagnostics Cancer Revenue by Manufacturer (2021)
Figure North America Molecular Diagnostics Cancer Revenue Market Share by Manufacturer in 2021
Table North America Molecular Diagnostics Cancer Sales by Type (2017-2022)
Table North America Molecular Diagnostics Cancer Sales Share by Type (2017-2022)
Table North America Molecular Diagnostics Cancer Sales by Application (2017-2022)
Table North America Molecular Diagnostics Cancer Sales Share by Application (2017-2022)
Figure Europe Molecular Diagnostics Cancer Revenue and Growth Rate (2017-2022)
Table Europe Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
Table Europe Molecular Diagnostics Cancer Sales Market Share by Countries (2017-2022)
Figure Europe Molecular Diagnostics Cancer Sales Market Share by Countries in 2021
Table Europe Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
Table Europe Molecular Diagnostics Cancer Revenue Market Share by Countries (2017-2022)
Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Countries in 2021
Figure Germany Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure UK Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure France Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Russia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Italy Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Spain Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Table Europe Molecular Diagnostics Cancer Revenue by Manufacturer (2021)
Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Manufacturer in 2021
Table Europe Molecular Diagnostics Cancer Sales by Type (2017-2022)
Table Europe Molecular Diagnostics Cancer Sales Share by Type (2017-2022)
Table Europe Molecular Diagnostics Cancer Sales by Application (2017-2022)
Table Europe Molecular Diagnostics Cancer Sales Share by Application (2017-2022)
Figure Asia-pacific Molecular Diagnostics Cancer Revenue and Growth Rate (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Molecular Diagnostics Cancer Sales Market Share by Countries in 2021
Table Asia-pacific Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Molecular Diagnostics Cancer Revenue Market Share by Countries in 2021
Figure China Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure South Korea Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Japan Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Australia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure India Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Figure Southeast Asia Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Revenue by Manufacturer (2021)
Figure Asia-pacific Molecular Diagnostics Cancer Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Molecular Diagnostics Cancer Sales by Type (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Sales Share by Type (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Sales by Application (2017-2022)
Table Asia-pacific Molecular Diagnostics Cancer Sales Share by Application (2017-2022)
Figure South America Molecular Diagnostics Cancer Revenue and Growth Rate (2017-2022)
Table South America Molecular Diagnostics Cancer Sales (Volume) by Countries (2017-2022)
Table South America Molecular Diagnostics Cancer Sales Market Share by Countries (2017-2022)
Figure South America Molecular Diagnostics Cancer Sales Market Share by Countries in 2019
Table South America Molecular Diagnostics Cancer Revenue by Countries (2017-2022)
Table South America Molecular Diagnostics Cancer Revenue Market Share by Countries (2017-2022)
Figure South America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2019
Figure Brazil Molecular Diagnostics Cancer Sales and Growth Rate (2017-2022)
Table South America Molecular Diagnostics Cancer Sales by T
Roche
Invitae
Abbott Laboratories
Danaher
MDxHealth
Siemens
Thermo Fisher Scientific
AstraZeneca
ICON Plc
PlexBio
Foundation Medicine
CytoTrack
Guardant Health
Luminex
10X Genomics
Merck
Biocartis
GenomOncology
Biodesix
Bio-Techne
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)